DILAPAN-S
healthcare economics

Discover how DILAPAN-S could transform labour induction—saving time for healthcare staff, reducing healthcare costs, while enhancing patient care and increasing maternal satisfaction. Learn more about the impact of DILAPAN-S.

DILAPAN-Shealthcare economics

Embrace a non-hormonal approach to labour induction that supports your medical team’s goals and enhances patient satisfaction.

11 %

Total cost savings with outpatient ripening

Up to10 hours

of hospitalisation time saving with outpatient ripening

2.4 hours

Midwife time saved per IOL

Only 1 %

of the total IOL cost is the cost of the ripening agent

DILAPAN-S - key contributions to the IOL health economics

Time savings

Time savings

  • Reduced workload
  • Shorter stay in hospital with outpatient ripening
Cost savings

Cost savings

  • Improved resource utilisation
  • Optimised patient flow
Improved patient care

Improved patient care

  • Superior maternal satisfaction
  • Significantly decreased analgesia requirements

Inpatient cervical ripening with DILAPAN-S

is cost-equivalent to the dinoprostone vaginal insert, whilst additionally saving 2.4 hours per induction of labour.

Time savings

Time savings

  • Reduced monitoring time
  • Lower rate of hyperstimulation
  • Significantly less analgesia requirements

Using data from SOLVE randomised clinical trial, a UK cost-consequence model compared two induction methods recommended by clinical guidelines (incl. NICE guideline): DILAPAN-S and dinoprostone vaginal insert. 

One of the key conclusions is that DILAPAN-S offers a time saving of up to 2.4 hours per induction.

Time savings
Cost neutrality

Cost neutrality

  • The methods were evaluated as cost neutral
  • DILAPAN-S offers savings during ripening phase
  • Increased need for oxytocin augmentation may affect cost of active phase of labour

Clinical feedback suggests that there is a significant variation between hospitals in the frequency of oxytocin need. Clinical research into ways of reducing the use of oxytocin after successful mechanical cervical ripening (e.g. mobilisation of induced women) may provide a new clinical data to further optimise patient care.

Cost neutrality

Are you interested in data from US?

Discover economic insights related to DILAPAN-S in the US market here.

Are you interested in data from US?

Outpatient cervical ripening with DILAPAN-S

may provide additional savings and further improve patient care.

Time saving and reduction of total hospital stay

Time saving and reduction of total hospital stay

  • Significant saving of around 10 hours from admission to active labour
  • Total hospital stay significantly reduced
  • Improved patient flow

The outpatient use of DILAPAN-S not only reduces hospital stay but may also increase maternal satisfaction. Importantly, it maintains a safety profile comparable to that of inpatient use.

Time saving and reduction of total hospital stay
Cost savings

Cost savings

  • Significantly shorter stay in hospital
  • Significantly higher VD24 rate* from admission
  • Reduction in analgesia use

The reduction in hospital stay and decreased staff time requirements associated with DILAPAN-S outpatient cervical ripening resulted in significant cost savings.

*VD24 rate — vaginal delivery rate within 24 hours

Cost savings

Are you interested in data from US?

Discover economic insights related to DILAPAN-S in the US market here.

Are you interested in data from US?

Upfront cost impact

  • The upfront cost of cervical ripening agent represents only around 1% of the total cost
  • Cost-effectiveness is usually determined by parameters other than the purchase price of the product itself

Factors such as safety, analgesia usage, and staff time contributed much more in this cost analysis. For example, see how DILAPAN-S outpatient ripening can bring significant cost savings.

Upfront cost impact

Navigating DILAPAN-S usage

Learn about DILAPAN-S mode of action, its functionality, and how it integrates into labour induction protocols for effective outcomes.

Navigating DILAPAN-S usage

Need to know more?​

Uncover a wealth of knowledge with our comprehensive resources and detailed FAQs.